Life sciences real estate has emerged as a premier property type, with the Boston-New York corridor representing the nation's largest concentration of biotech and pharmaceutical tenants.
Market Dynamics
- Limited purpose-built lab space in NYC
- Strong institutional and venture capital funding
- Academic medical center partnerships driving demand
- Conversion opportunities from office to lab
Investment Opportunities
Office-to-lab conversions offer attractive returns for sponsors with development expertise and tenant relationships. Build-outs are expensive, creating tenant stickiness.